Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with schizophrenia who are between 18 and 55 years old
- People who have ongoing, persistent negative symptoms of schizophrenia, measured by a specific symptom scale scoring above 7 (confirm with trial site for what this means in practice)
- People who are regularly seen and monitored by a psychiatry department
- People who have no medical reasons preventing them from doing physical activity
- People who are covered by or entitled to a social security system
- People who have been fully informed about the study and have signed a consent form together with the investigator
- Men or women are eligible
Who may not be able to join:
- People the investigator considers unsuitable for the study for any reason
- People who have ongoing joint problems, such as repeated sprains or knee and ligament issues, or who have heart conditions
- People who have long-term or brain-related neurological conditions
- People who are in custody or who are under legal guardianship or protection
- People who drink more than 14 alcoholic drinks per week, or consume more than 400 mg of caffeine per day (roughly more than 4 standard cups of coffee)
- Women who are pregnant
- People who are unable to understand the purpose and conditions of the study or who are unable to give informed consent
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Medhi HOUSNI, Md, CHU de Saint-Etienne
Phone: (0)477127885
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Self-evaluation of negative symptoms (SNS) questionnaire
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.